Newbridge Financial Services Group’s Quest Diagnostics DGX Stock Holding History

Newbridge Financial Services Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.51K	Hold	26	–	–	﹤0.01%	951
2026 Q1	$5.09K	Buy	+26	New	+$5.05K	﹤0.01%	917
2023 Q4	–	Sell	-15	Closed	-$1.79K	–	1204
2023 Q3	$1.79K	Hold	15	–	–	﹤0.01%	1088
2023 Q2	$2.05K	Hold	15	–	–	﹤0.01%	1130
2023 Q1	$2.06K	Buy	15 +1	+7%	+$143	﹤0.01%	1193
2022 Q4	$2.26K	Hold	14	–	–	﹤0.01%	1196
2022 Q3	$2K	Hold	14	–	–	﹤0.01%	1186
2022 Q2	$2K	Hold	14	–	–	﹤0.01%	1166
2022 Q1	$2K	Hold	14	–	–	﹤0.01%	1278
2021 Q4	$2K	Hold	14	–	–	﹤0.01%	1228
2021 Q3	$2K	Sell	14 -61	-81%	-$8.93K	﹤0.01%	1172
2021 Q2	$10K	Hold	75	–	–	0.01%	980
2021 Q1	$10K	Buy	75 +14	+23%	+$1.73K	0.01%	893
2020 Q4	$7K	Sell	61 -573	-90%	-$69.9K	0.01%	783
2020 Q3	$73K	Buy	+634	New	+$74.9K	0.07%	239

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Newbridge Financial Services Group's DGX Position: Q2 2026 in Review

Newbridge Financial Services Group held its Quest Diagnostics (DGX) position steady in Q2 2026 at 26 shares worth $5.51K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Newbridge Financial Services Group first reported a position in DGX in Q3 2020 and has held it in 15 quarters since. The position peaked at $73K in Q3 2020. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Newbridge Financial Services Group held 26 shares of Quest Diagnostics worth $5.51K as of Q2 2026.
Newbridge Financial Services Group left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #951 holding.
Newbridge Financial Services Group first reported a position in Quest Diagnostics in Q3 2020 and has held it in 15 quarters since.
Newbridge Financial Services Group's Quest Diagnostics position peaked at $73K in Q3 2020.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.